Budding et al. were the first to investigate the role of CD59 in lung transplant, showing that in chronic lung allograft dysfunction, BOS patients had higher serum concentrations of sCD59 than non-BOS patients [56]. Here, CD59 is linked to Buschke-Ollendorff syndrome.